Zostervax (Shingles Vaccine) Update
We are back to normal supplies with Zostervax immunisations and have attempted to contact all patients on the Zostervax waiting list. If you have been on the waiting list and may have missed our calls, please contact our friendly reception team on (02) 8068 2490 to schedule you immunisation.
Who is eligible for the Government Zostervax Immunisation?
In November 2016, The shingles vaccine, Zostavax®, was approved to be placed on the National Immunisation Program (NIP), provided free of charge to people aged 70 years, subject to vaccine supply. There will also be a five year catch-up program for people aged 71 – 79 years.
Please note that we also stock private supply of Zostervax immunisations for those who are not eligible to receive a government funded vaccine. If you are interested in having the vaccine, please contact our friendly reception team on (02) 8068 2490 or book an appointment online to discuss this with your Doctor.
Note: It is recommended for patients 50 years and older who are not eligible for the government immunisation program.
What is Shingles?
Shingles is a painful rash caused by reactivation of the varicella zoster virus – the same virus that causes chickenpox. 1 in 3 people will develop shingles in their lifetime. As a person gets older, the risk of getting shingles and neurological complications increases.
BEXSERO® supplies have returned to normal. We have contacted everyone on our waiting list. If you are interesting in commencing the BEXSERO® schedule, please contact our friendly reception team or book an appointment online to discuss this with your Doctor.
What is BEXSERO® and what is it used for?
BEXSERO® is a meningococcal group B vaccine.
BEXSERO® is given to individuals from 2 months of age and older to help protect against disease caused by bacteria called Neisseria meningitidis group B. These bacteria can cause serious, and sometimes life-threatening, infections such as meningitis (inflammation of the covering of the brain and spinal cord) and sepsis (blood poisoning).
The vaccine works by specifically stimulating the body’s natural defense system of the vaccinated person. This results in protection against this disease.
Who should consider having the BEXSERO® immunisation?
Based on their higher disease risk, 4CMenB is recommended for these groups:
- Infants and young children, particularly those aged <24 months
- Adolescents aged 15 to 19 years
- Children and adults with medical conditions that place them at a high risk of IMD, such as functional or anatomical asplenia or complement component disorders
- Laboratory personnel who frequently handle Neisseria meningitidis
Worldwide, the main strains that cause meningococcal disease are A, B, C, W and Y. ** Doctors on Darling also stock the ACWY vaccine